{
  "id": 16910983,
  "title": "TROP2 ADCs: The race to capture the next oncology opportunity",
  "url": "https://urgent.news/2026/10/28/trop2-adcs-the-race-to-capture-the-next-oncology-opportunity",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-28T09:00:00.000Z",
  "source": {
    "name": "Labiotech",
    "slug": "labiotech",
    "url": "https://www.labiotech.eu/in-depth/trop2-adcs/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Look into the landscape around TROP2 ADCs as frontrunners aim to expand and the next wave aims to develop safer drugs. The post TROP2 ADCs: The race to capture the next oncology opportunity appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}